{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-001198","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2026-07-17T20:34:51+00:00","discovered_at":"2026-07-17T20:36:01.582284+00:00","generated_at":"2026-07-17T20:36:06.981377+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Artelo Biosciences shareholders approve increase in authorized shares and share issuance at 2026 annual meeting","bullets":["Three Class III directors re-elected: Reyes (179,416 for), Favorito (176,821), Gorgas (171,567); broker non-votes 937,382.","Amendment to increase authorized common stock from 166,666,667 to 500,000,000 approved: 985,717 for, 164,845 against, 21,641 abstain.","Share issuance >20% under Equity Purchase Agreement with Square Gate Capital Master Fund approved: 91,158 for, 65,155 against, 78,508 abstain, 937,382 broker non-votes.","Approximately 41.2% of outstanding shares (1,172,203 of 2,848,540) represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-001198","json":"https://secwatch.observer/filing/0001640334-26-001198.json","markdown":"https://secwatch.observer/filing/0001640334-26-001198.md","text":"https://secwatch.observer/filing/0001640334-26-001198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426001198/0001640334-26-001198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426001198/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:36:06.981377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}